Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether–lumefantrine treatment in Mali

JOURNAL ARTICLE published December 2017 in Malaria Journal

Research funded by European and Developing Countries Clinical Trials Partnership (IP_07_31060_002) | Wellcome Trust (087536/Z/08/Z) | Medicines for Malaria Venture (SP-C-013-11) | International Atomic Energy Agency (AT) (RAF/06)

Authors: Souleymane Dama | Hamidou Niangaly | Amed Ouattara | Issaka Sagara | Sekou Sissoko | Oumar Bila Traore | Amadou Bamadio | Niawanlou Dara | Moussa Djimde | Mohamed Lamine Alhousseini | Siaka Goita | Hamma Maiga | Antoine Dara | Ogobara K. Doumbo | Abdoulaye A. Djimde